Basket | Login | Register

 
 
 
 

2009 Accounts

Financial accounts


Balance sheet as of December 31, 2009

 

2009 (EUR)

2008 (EUR)

ASSETS

   

Current assets

   

Debtors EU Commission - Eurocode

174,745

174.745

Other debtors

67,963

19,680

Advance payments - Eurocode partners

-

10,265

Cash at bank and on deposit

136,470

202,962

 

379,178

407,652

Accruals

7,687

9,590

Total Assets

386,865

417,242

     

LIABILITIES

   

Capital and reserves

   

Results brough forward

145,088

106,758

Result of the year

17,587

38,330

 

162,675

145,088

Creditors

   

Amounts owed to credit institutions

990

-

Payments received on account - Other

22,919

83,798

Trade creditors

36,655

48,235

Creditors - Eurocode partners

131,352

131,352

Other liabilities

32,274

8,768

 

224,190

272,154

Total Liabilities

386,865

417,242


Profit and loss account – Year ended December 31, 2009

 

2009 (Euro)

2008 (Euro)

Support and revenue

   
     

Other operating income

   

Corporate sponsorship

356,484

323,664

Sponsorship received on account

- 22,919

- 83,798

EU Subsidy

 

79,503

Co-financing in kind

108,463

93,832

Membership fees

46,500

48,000

Donations

630

485

Publication sales and royalties

2,572

9,873

Internet services

 

2,220

Project participation

70,222

21,310

Other operating revenue

15,004

6,479

AE Conference and registrations

91,875

22,989

Unpayable debts

 

399

Eurocode Partner Income

 

333,146

     

External charges

   

External experts

- 218,041

- 160,041

Publication and Information material

- 59,478

- 58,054

Travel expenses

- 24,285

- 29,663

Communication costs

- 35,502

- 22,010

Accommodation expenses

- 82,768

- 37,316

Office rent and associated costs

- 26,105

- 23,981

Office stationery and related costs

- 2,838

- 2,510

Equipment & Leasing

- 17,708

- 12,236

Membership fees

- 220

- 1,120

Other costs

- 2,404

- 2,481

Irrecoverable debt

- 6,275

 

Eurocode Partner Expenses

 

- 333,146

     

Staff costs

   

Wages and salaries

- 136,739

- 112,614

Social security costs

- 37,873

- 31,204

     

Interest receivable and similar income

1,144

7,108

     

Interest payable and similar charges

- 2,151

- 504

     
     
 

17,587

38,330


Introduction

In 2009, Alzheimer Europe had an audited income of EUR 692,894.74 of which EUR 350,510.24 (50.59%) were for the organisation’s core activities (including the organisation’s Dementia Ethics Network and Annual Conference) and EUR 342,384.50 (49.41%) were for the organisation’s public affairs activities.

Funding of core activities (EUR 350,510.24)

In 2009, the core funding of Alzheimer Europe was composed as follows:

  • EUR 150,371.28 (42.90%) from member organisations,
  • EUR 89,905.33 (25.65%) from individuals,
  • EUR 51,222.21 (14.61%) from public funding,
  • EUR 36,750 (10.48%) from corporate sources,
  • EUR 15,000 (4.28%) from foundations and other non-profit organisations,
  • EUR 6,117.15 (1.75%) from other sources and
  • EUR 1,144.27 (0.33%) from bank interest and similar.

Funding from member organisations

In 2009, the EUR 150,371.28 funding from member organisations can be broken down as follows:

  • EUR 91,107.31 in co-financing from the Luxembourg member organisation through the secondment of the AE Executive Director,
  • EUR 46,500 in membership fees,
  • EUR 12,000 in co-financing from the Luxembourg member organisation by providing the offices of Alzheimer Europe free of rent,
  • EUR 763.97 in co-financing from member organisations covering the travel expenses of AE Board members to attend Board meetings.

Individuals

In 2009, AE received EUR 89,905.33 from individuals which can be broken down as follows:

  • EUR 86,875 in conference registrations,
  • EUR 2,572.33 in publication sales and
  • EUR 458 in donations.

Public funding

In 2009, Alzheimer Europe received EUR 51,222.21 from the German Ministry of Health to cover the expenditure for the setting up of the European Dementia Ethics Network.

In 2009, Alzheimer Europe did not receive funding from the European Commission or other European agencies.

Corporate support

In 2009, Alzheimer Europe received EUR 36,750 from corporate sources as core-funding which can be broken down as follows:

  • EUR 10,000 from Janssen-Cilag and Pfizer as support to the Alzheimer Europe Conference in Brussels,
  • EUR 5,000 from Lundbeck and Multimount as support to the Alzheimer Europe Conference in Brussels,
  • EUR 3,750 from Wyeth as support to the Alzheimer Europe Conference in Brussels,
  • EUR 3,000 as co-financing from Mazars which carried out the audit of the organisation’s accounts free of charge.

Foundations and organisations

The EUR 15,000 which Alzheimer Europe received in 2009 from foundations and other non-profit organisations can be broken down as follows:

  • EUR 5,000 from Fondation Médéric Alzheimer, Fondation Roi Baudouin and EUR Mutualités libres to support the Alzheimer Europe Conference in Brussels,

Bank interest and similar

In 2009, Alzheimer Europe had an income of EUR 1,144.27 from bank interest and similar income.

Other income

In 2009, EUR 6,117.15 came from other sources not mentioned above.

Funding of public affairs activities (EUR 342,384.50)

In 2009, Alzheimer Europe received EUR 342,384.50 for its public affairs activities, of which

  • EUR 239,107.68 (69.83%) came from corporate sponsors,
  • EUR 83,798.13 (23%) from reserves brought forward from the financial year 2008,
  • EUR 9,000 from foundations and organisations,
  • EUR 1,591.98 from member organisations and
  • EUR 8,886.71 from other sources.

Corporate support

The corporate support received by Alzheimer Europe for its public affairs activities can be broken down as follows:

  • Pfizer contributed EUR 40,000 as a gold sponsor and EUR 826.20 in travel support,
  • Novartis contributed EUR 40,000 as a gold sponsor and EUR 294.95 in travel support
  • Janssen-Cilag contributed EUR 40,000 as a gold sponsor,
  • GlaxoSmithKline contributed EUR 35,287.80 as a gold sponsor and EUR 1,027.76 in travel support and honoraria,
  • Lundbeck contributed EUR 20,000 as a silver sponsor and EUR 2,152.40 in travel support and honoraria,
  • Lilly contributed EUR 20,000 as a silver sponsor and EUR 2,000 in travel support and honoraria,
  • Wyeth contributed EUR 20,000 as a silver sponsor,
  • Elan contributed EUR 9,263.44 as a bronze sponsor,
  • Sudler & Hennessy contributed EUR 6,761.35 in travel support and honoraria,
  • Huntsworth Health contributed EUR 1,143.46 in travel support and honoraria,
  • Bayer contributed EUR 178 in travel support,
  • Alzheimer Europe received a donation of EUR 172.32 from Mark Krueger and Associates.

Reserves

In 2009, Alzheimer Europe was able to contribute EUR 83,798.13 of its own reserves to its public affairs activities which came from income received on account in 2008.

Foundations and organisations

In 2009, Alzheimer Europe received EUR 9,000 from Fondation Médéric Alzheimer for the work carried out on the inventory of national legislation on healthcare decision making and the publication of its 2009 Dementia in Europe Yearbook.

Member organisations

Members contributed EUR 1,591.98 in 2009 in co-financing for travel expenditure incurred by member organisations for public affairs meetings organised by AE.

Other income

In 2009, EUR 8.886.71 came from sources not included above.

Overall funding

The following table lists all sources of income received in 2009. In line with the policy of the European Medicines Agency on transparency requirements for accredited patients’ organisations, this is presented in total amounts as well as in terms of percentages of the overall income of the organisation.

Funding source

Funding received (2009)

as % of AE Income (2009)

Pfizer

50,826.20

7.34%

Janssen-Cilag

50,000.00

7.22%

Novartis

40,294.95

5.82%

GlaxoSmithKline

36,315.56

5.24%

Lundbeck

27,152.40

3.92%

Wyeth

23,750.00

3.43%

Lilly

22,000.00

3.18%

Elan

9,263.44

1.34%

Bayer

178.00

0.03%

Sub-total: Phamaceutical funding

259,780.55

37.49%

Sudler &Hennessy

6,761.35

0.98%

Multimount

5,000.00

0.73&

Mazars

3,000.00

0.43%

Huntsworth Health

1,143.46

0.17%

Mark Krueger and Associates

172.32

0.02%

Sub-total: Other corporate funders

16,077.13

2.32%

TOTAL: Corporate Sources

275,857.68

39.81%

Association Luxembourg Alzheimer

103,107.31

14.88%

Membership dues

46,500.00

6.71%

Travel borne by member organisations

2,328.95

0.34%

TOTAL: Members

151,963.26

21.93%

Individuals

89,905.33

12.98%

TOTAL: Individuals

89,905.33

12.98%

Reservers brough forward

83,798.13

12.09%

TOTAL: Reserves

83,798.13

12.09%

German Ministry of Health

51,222.21

7.39%

European Commission and other European funding

0.00

0.00%

TOTAL: Public Funding

51,222.21

7.39%

Fondation Médéric Alzheimer

14,000.00

2.02%

Fondation Roi Baudouin

5,000.00

0.73%

Mutualités libres

5,000.00

0.73%

TOTAL: Foundations and organisations

24,000.00

3.46%

Bank interest and similar

1,144.27

0.17%

TOTAL: Bank interest and similar

1,144.27

0.17%

Other sources

15,003.86

2.17%

TOTAL: Other sources

15,003.86

2.17%

 

 

Downloads

 

 

Last Updated: Tuesday 18 January 2011

 

 
 

Options